ENRIQUE OVIEDO: Open Payments
NPI 1255534756 · DUNDALK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,168 in 70 payments from 7 companies in 2025. Trend: 2023 $554 · 2024 $714 · 2025 $15,168
Speaker / faculty: $9,568Travel & lodging: $3,091Food & beverage: $2,509
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 54 | $14,042 |
| Braeburn Inc. | 4 | $489 |
| Supernus Pharmaceuticals, Inc. | 8 | $267 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| TMS NeuroHealth Centers Inc. | 1 | $109 |
| Neos Therapeutics, LP | 1 | $17 |
Products named: SUBLOCADE, BRIXADI, Qelbree, COBENFY, Auvelity, TMS NeuroHealth Centers Inc., Cotempla XR-ODT.
Industry payments across MD — which companies pay providers there.
